Trading Algorithm

An insider is legally permitted to buy and sell shares of the firm – and any subsidiaries – that employs him or her. However, these transactions must be properly registered with the Securities and Exchange Commission (SEC) and are done with advance filings. You can find details of this type of insider trading on the SEC’s EDGAR database. This algorithmic forecast is for stocks with recently reported insiders’ transactions.An “insider” is any person who possesses at least one of the following:

• access to valuable non-public information about a corporation (for example a company’s directors and high-level executives)
• ownership of more than 10% of the company’s equity

Package Name: Insiders Stocks
Recommended Positions: Long & Short
Forecast Length: 1 Year (01/24/2018 – 01/24/2019)
I Know First Average: 35.67% (Long) & 38.84% (Short)

During the 1 Year forecast, the algorithm had predicted high returns for those seeking stock advice. The best performance in the short position came from ACET which registered a return of 88.80%. For the long positions the largest growth was registered by AMRN with a return of 299.32%, during the same period. The package itself, had an overall average return of 35.67%, in the long position, providing a premium of 42.60% over the SP500’s return of -6.93%. With regards to the short position, the package had an overall average return of 38.84%, providing investors with a premium of 45.77% over S&P500’s return of -6.93%. The I Know First’s Stock Market Algorithm accurately forecasted 7 out of 10 stocks, for the long position, and 9 out of 10 stocks, for the short position for this 1 Year forecasted period.

Amarin Corporation plc, incorporated on March 1, 1989, is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company’s lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

How to interpret this diagram:

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.